|
Originally published In Press as doi:10.1074/jbc.M100951200 on April 9, 2001
J. Biol. Chem., Vol. 276, Issue 26, 24223-24231, June 29, 2001
Microarray Analysis Reveals Previously Unknown
Changes in Toxoplasma gondii-infected Human Cells*
Ira J.
Blader ,
Ian D.
Manger§, and
John C.
Boothroyd¶
From the Department of Microbiology and Immunology, Stanford
University, Stanford, California 94305-5124
Received for publication, February 1, 2001, and in revised form, April 4, 2001
 |
ABSTRACT |
Cells infected with the intracellular protozoan
parasite Toxoplasma gondii undergo up-regulation of
pro-inflammatory cytokines, organelle redistribution, and protection
from apoptosis. To examine the molecular basis of these and other
changes, gene expression profiles of human foreskin fibroblasts
infected with Toxoplasma were studied using human cDNA
microarrays consisting of ~22,000 known genes and uncharacterized
expressed sequence tags. Early during infection (1-2 h), <1%
of all genes show a significant change in the abundance of their
transcripts. Of the 63 known genes in this group, 27 encode proteins
associated with the immune response. These genes are also up-regulated
by secreted, soluble factors from extracellular parasites indicating
that the early response does not require parasite invasion. Later
during infection, genes involved in numerous host cell processes,
including glucose and mevalonate metabolism, are modulated. Many of
these late genes are dependent on the direct presence of the parasite;
i.e. secreted products from either the parasite or infected
cells are insufficient to induce these changes. These results reveal
several previously unknown effects on the host cell and lay the
foundation for detailed analysis of their role in the host-pathogen interaction.
 |
INTRODUCTION |
Toxoplasma gondii, which is an obligate intracellular
apicomplexan parasite that can infect most nucleated cells, causes
devastating disease in humans and is related to Plasmodium,
the causative agent of malaria (1). Immediately following invasion,
T. gondii resides and replicates within a parasitophorous
vacuole that, although free of host membrane proteins, is surrounded by
host mitochondria and endoplasmic reticulum (2). Once the parasite begins growing and dividing within the parasitophorous vacuole, it must
acquire nutrients such as purine nucleosides and cholesterol from the
host cell (3). The mechanisms by which the morphological and metabolic
changes to the host cell occur are unknown.
T. gondii infection also causes the induction of numerous
immune modulators that activate both the innate and adaptive immune responses (4-7). Both live parasites and parasite extracts stimulate IFN- 1 synthesis, which is
required for protection, primarily via dendritic cell activation (6, 8,
9). However, the mechanism by which infected cells activate and recruit
dendritic cells remain unclear but presumably requires synthesis of C-C
chemokines that bind and activate the C-C chemokine receptor, CCR5
(10). Although previous data demonstrated that T. gondii-infected cells produce these chemokines, the molecular
mechanisms that regulate their expression are still unknown (4, 5, 7).
Moreover, the full repertoire of host genes whose expression is
modulated by T. gondii as well as the signal transduction
cascades underlying these changes are also unknown.
Recently, the study of host-parasite interactions has been greatly
aided by large-scale gene expression analysis using DNA microarrays
(11). Spotted with grids of highly dense and organized spots of DNA,
cDNA microarrays are hybridized to two different cDNA samples
each labeled with a different fluorophore thus allowing the
simultaneous monitoring of differential gene expression for thousands
of genes (12). Recent studies using microarrays have enhanced our
knowledge of the host response to viruses (e.g. human immunodeficiency virus, cytomegalovirus, and coxsackievirus) and bacteria (e.g. Salmonella typhimurium,
Pseudomonas aeruginosa, and Listeria
monocytogenes) (13-18). Microarrays demonstrated that the
transcriptional response of macrophages to lipopolysaccharide and
Salmonella are largely overlapping, suggesting that
lipopolysaccharide may be largely responsible for the inflammatory
response to Salmonella (14).
The goal of our study was to analyze the global changes that occur when
a protozoan intracellular parasite infects a mammalian host cell. Thus,
we examined the transcriptional profile of HFFs in response to T. gondii infection. Intact parasites, as well as soluble
parasite-derived factors, rapidly increase the abundance of transcripts
associated with the immune response. Later following infection,
numerous host genes were modulated that are involved in diverse
cellular processes, including metabolism, transcription, protein
targeting, and apoptosis. Finally, we were able to discriminate between
genes that are modulated due to either parasite- or host cell-derived
secreted factors and those that are modulated only in the presence of
intracellular parasites.
 |
EXPERIMENTAL PROCEDURES |
Cells, Parasites, and Reagents--
HFFs (passage 10-16
post-isolation) were used for all assays. The PDS strain of T. gondii, cloned from ME49 (19), was routinely passaged in HFFs
using standard T. gondii culture conditions (19) with DMEM
supplemented with 10% fetal bovine serum, 2 mM glutamine, and gentamicin (Life Technologies; Rockville, MD). HFF and parasite strains were regularly inspected for mycoplasma, and found to be
negative, using a Mycoplasma PCR ELISA detection kit (Roche Molecular
Biochemicals; Indianapolis, IN).
Parasite Preparation and Infection Assays--
Parasites were
harvested from infected HFF monolayers when lysis by infection was
almost completed and few, if any, intact host cells remained. The
flasks were then scraped, and the entire material harvested and passed
twice through a 27-gauge needle to rupture any remaining HFFs and
release the parasites within. The resulting material was pelleted at
600 × g, washed three times in serum-free DMEM, and
parasites counted by light microscopy. No intact host cells could be
detected in this preparation. Parasites were added to HFF monolayers
(4-7 days old) at an multiplicity of infection of 5-10. Infection
assays were routinely performed with HFF monolayers in
75-cm2 flasks grown in 15 ml of media or a proportionate
volume for different size flasks for the indicated times. For the
Transwell experiments, HFFs were plated in the lower chamber of
a 10-cm Transwell tissue culture insert (final volume 10 ml;
Corning-Costar, Corning, NY) with 5 ml of media in the upper chamber.
Parasites, in serum free media, were added to the upper chamber, and
the plates were incubated for 4 h.
RNA Preparation--
Total RNA was prepared using the RNAeasy
Midi kit (Qiagen, Valencia, CA). The amount of T. gondii
total RNA co-purified 24 hpi was estimated to be ~20% by comparing
ribosomal RNA band intensities of total RNA separated by agarose gel
electrophoresis (not shown).
Microarray Hybridization--
cDNA microarrays were
synthesized at Stanford University using standard protocols (12). The
microarrays were spotted with 18,000-27,000 sequence-verified clones
that are available from Research Genetics (Huntsville, AL). cDNA
probe preparation was performed essentially as described previously
(12). Briefly, total RNA (20-25 µg) was converted to first-strand
cDNA using Superscript II (Life Technologies, Rockville, MD) with
oligo-dT18 (New England BioLabs, Bedford, MA). The cDNA
was labeled with Cy3-dUTP (infected) or Cy5-dUTP (uninfected) (Amersham
Pharmacia Biotech, Uppsala, Sweden) via a random prime reaction using
random nanomer. We found that labeling cDNA with random
nanomer versus direct dye incorporation during the
first-stand cDNA synthesis reaction (12) did not indicate any
significant difference between the two protocols (not shown).
Microarrays were hybridized overnight at 65 °C, washed as described
(12) and scanned with a GenePix 4000 microarray scanner (Axon
Instruments, South San Francisco, CA). Each time point and condition
was repeated typically three-five times.
Data Analysis--
Microarrays were analyzed with the Scanalyze
program (written by Mike Eisen and available on the Web) to
determine the fluorescent intensities of the two dyes for each spot.
The fluorescence intensities were normalized by applying a scaling
factor so that the median fluorescence ratio of all spots with
detectable signals above background on each microarray was 1.0 (20).
The data were then filtered such that only spots with intensities that
were three times greater than background in either channel were used in
the analysis. Only those spots that displayed a 2-fold or greater difference in fluorescence intensities between the two dyes were used
to generate gene clusters. For all such clusters, each spot was
manually examined to assess its quality and those that exhibited poor
quality throughout the analysis were removed. Spots of poor quality in
individual microarrays were discarded from the dataset and are
represented in the gene clusters as gray bars. Poor quality spots were removed if they were 1) very small, 2) irregularly shaped,
or 3) with pixels that were not uniformly distributed throughout the
spot. In the gene clusters, black bars represent genes that
displayed -fold changes of 2 or less. Data clustering was performed
using the Cluster program and figures generated using Tree View (both
available on the Web) (21).
Northern Blot--
Total RNA (5 µg) was separated by agarose
gel electrophoresis using standard molecular biological techniques.
GRO1 cDNA was prepared by RT-PCR from total RNA from
T. gondii-infected HFFs using the following
oligonucleotides: GRO1-F 5'-CGGAAAGCTTGCCTCAATCCT-3' and GRO1-R
5'-GATCCGCCAGCCTCTATCACA-3'. -actin (IMAGE:
867606) and DKK1 (IMAGE: 669375) cDNAs were purchased
from Research Genetics (Huntsville, AL) and were sequenced-verified.
Probes were labeled with [ -32P]dGTP with the Random
Primed DNA labeling kit (Roche Molecular Biochemicals, Germany) and
hybridized with Express-Hyb (CLONTECH, Palo Alto,
CA) according to the manufacturer's instructions. Blots were exposed
to film, and the autoradiographs were scanned and analyzed using the
ImageQuaNT analysis program (Molecular Dynamics, Sunnyvale, CA)
ELISA--
Secreted GRO1 protein was detected by ELISA using the
GRO1 ELISA kit (R&D Systems, Minneapolis, MN) according to the
manufacturer's protocol.
 |
RESULTS |
Human Microarrays to Study Host Response to T. gondii--
To
characterize the host cell response to T. gondii infection,
we employed cDNA microarray analysis, which is a powerful tool for
analyzing global changes in gene expression. Because this technique can
be subject to variability due to a combination of RNA preparation and
handling, spot quality, and data analysis (15), it is necessary first
to determine the experimental error for the conditions being used. Once
determined, these variables allow thresholds to be set below which
changes are not regarded as significant. Thus, HFF cultures were
mock-infected or infected with T. gondii tachyzoites for
14 h in duplicate, and RNA was isolated from infected and
mock-infected cells. HFFs were used in this study, because they are a
well characterized T. gondii cell culture model. Moreover,
they are non-transformed and do not require pretreatment with
differentiation factors, such as growth factors or phorbol esters,
which limit the extent of variability between cell preparations.
Microarrays were then hybridized with cDNA probes synthesized using
RNA from the infected and the mock-infected samples. We compared the
difference between infected and uninfected cells for each spot whose
signal intensity in either channel was at least 500 fluorescence units,
which corresponds to three times greater than background. Using this
filter, 11,976 spots (45% of the total number of spots) were included
in the analysis. To assess assay reproducibility, the fold difference
for each spot was plotted for the two duplicate experiments (Fig.
1A). The data showed a linear
regression of 0.88, indicating a generally high level of correlation.
Next, the 11,976 spots were filtered to include only spots of high
quality that displayed a fluorescence ratio between infected and
uninfected cells of >2 in either microarray. Using these criteria, a
total of 1503 spots (~6% of the original 11,976 spots) were analyzed
with a regression correlation of r = 0.95 (Fig.
1B). Similar analysis demonstrated that no significant bias
was observed when the Cy3-dUTP and Cy5-dUTP labels were reversed (not
shown).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Microarray assay reproducibility.
A, cDNA, prepared from mock- or parasite-infected
HFFs for 14 h in duplicate, were hybridized to microarrays.
Scatter plot depicting the Cy5-dUTP/Cy3-dUTP ratio for corresponding
spots between the two microarrays. Spots were included that had a
signal strength of three times over background in both microarrays
(n = 11,976, 45% of total). The black line
indicates the regression correlation (r = 0.88), and
the red line represents a perfect correlation of 1.0. B, spots from A were filtered for those of high
quality and displayed a -fold change of two or greater in at least one
of the microarrays (n = 1503, 6% of total). The
black line indicates the regression correlation
(r = 0.95). C, gene cluster of the data from
B. Each row represents a spot on the microarray
and each column a separate microarray. Note the high degree
of correlation (represented by color intensities) between
the two experiments.
|
|
Because T. gondii is an intracellular parasite, the RNA
preparation protocol used resulted in the purification of not only HFF
RNA but also parasite RNA. Thus, the apparent gene modulation observed
could have conceivably been an artifact due to cross-hybridization between T. gondii cDNA and spots on the human
microarray. To control for this, a human cDNA microarray was
hybridized with Cy5-dUTP-labeled cDNA probe made from 20 µg of
uninfected HFF RNA and Cy3-dUTP-labeled cDNA probe made from 16 µg of uninfected HFF RNA to which 4 µg (20%) total parasite RNA,
prepared from washed and filtered tachyzoites, was added. Data analysis
indicated that T. gondii cDNA does not cross-hybridize
to any measurable extent with any spot on the human microarray (not shown).
Because the parasites were cultured in vitro in
HFF monolayers and purified by syringe-lysis, host cell debris
remaining in the parasite preparation could have modulated gene
expression in uninfected monolayers. Thus, the response of HFFs
infected for 2 h with T. gondii were compared with HFFs
treated with an equivalent preparation of uninfected HFFs, which were
scraped and prepared using conditions identical to those used to
prepare the parasites. Two different microarrays were hybridized with either cDNA from the parasite-infected or debris-treated cells against cDNA from untreated HFFs. The microarray from the cell debris-treated sample showed no significant changes in gene expression whereas the infected cells displayed the usual profile of gene induction (not shown). These data indicate that the changes in gene
expression detected by microarrays are real, reproducible, and the
result of T. gondii infection.
T. gondii Stimulates Rapid Induction of Pro-inflammatory
Genes--
To dissect the temporal response of HFFs infected with
T. gondii, a time course was performed during which RNA was
purified from HFFs that were mock- or parasite-infected for 1, 2, 4, 6, and 24 hpi with T. gondii tachyzoites. To minimize host cell
lysis following parasite egress, the time course was limited to 24 h and we used the PDS strain, a ME49 clonal derivative, that grows more
slowly than the highly virulent Type 1 RH strain (doubling time of
~12 h (PDS) versus ~6-8 h (RH)) (19). For each time point, a microarray was used to compare cDNA prepared from
mock-infected versus parasite-infected cells. Following
hybridization, the data were filtered based on the criteria described
above: spots were three times greater than background in at least one
channel, of high quality, and displayed a 2-fold change or greater
(relative to uninfected) in at least one time point during the
experiment. The filtered data were organized into temporal gene
expression clusters. This approach was previously used to classify
cell-cycle-regulated genes in Saccharomyces cerevisiae and
identify serum responsive genes in HFFs (21-23). Clustering of the
time course data indicated that two distinct gene expression patterns
were present: genes that are modulated rapidly after infection (1-2
hpi) and those that are modulated later (>6 hpi) (Fig.
2). Due to the large number of genes
modulated during the time course, only data related to genes that have
some functional information are shown and discussed. The full
group, including ESTs and genes not discussed here, can be
downloaded from J.C.B.'s website at Stanford University.

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 2.
Transcriptional response of HFFs infected
with T. gondii for 1-24 h. A, gene
cluster of spots of high quality representing unique, known genes that
change >2-fold at least once during the time course. B,
enlarged view of the cluster from A showing the genes that
are modulated 1-2 hpi. *, genes known to be associated with the immune
response.
|
|
During the first 2 h of infection, a total of 63 unique, known
genes exhibited a 2-fold or greater increase in their abundance, whereas 15 unique, known genes exhibited a 2-fold or greater decrease. A high proportion of the induced genes (27 genes, 43%), are genes previously known to be associated with the immune response. These immunomodulatory molecules include chemokines (GRO1,
GRO2, LIF, and MCP1), cytokines
(IL-1 , IL-6), cell matrix and adhesion
proteins (ICAM1 and matrix metalloproteinase 3),
apoptotic (superoxide dismutase 2) and transcriptional
regulatory factors (REL-B, NF- B p105, I- B ). Several additional
cytokines previously shown to be important in T. gondii
infection, such as -interferon,
IL-10, and IL-12 (24, 25), were not among the
genes spotted on the microarrays and therefore were not included in
this analysis. Although TNF- and IFN- ,
which is not normally expressed in HFFs, were not spotted on the
microarrays used for this time course, subsequent microarray
experiments, using microarrays that included TNF- and
IFN- , showed that they were not induced even by 24 hpi
(not shown). Although the early induced genes are predominantly associated with the immune response, these represent a relatively small
number of immune response genes spotted on the microarrays. For
example, only 4 out of 24 genes encoding chemokines and 2 out of 41 genes encoding interleukins or their receptors were up-regulated by
T. gondii 2 hpi.
Northern Blot Confirmation of Microarray Data--
Although
microarrays are a powerful tool to study global transcriptional
responses to infection, it is important to confirm microarray data
using independent methods such as Northern blot analysis, ribonuclease
protection assay, or quantitative reverse transcription-polymerase
chain reaction. Northern blots of representative genes from among those
induced, repressed, or unchanged by infection were performed to verify
the microaray data. RNA prepared from uninfected and infected cells
(2 and 24 hpi) were used to make cDNA for hybridization to the
microarrays and for analysis by Northern blotting using probes for an
up-regulated gene (GRO1), a down-regulated gene
(DKK1), and an unmodulated gene
( -actin). The Northern blot data were
consistent with the microarrays providing an independent validation of
the microarray data (Fig. 3). Although -actin remained unchanged by both microarray and Northern blot analysis, it was observed that GRO1 was up-regulated and
DKK1 was down-regulated with both techniques. Importantly,
the Northern blot data corroborated the microarray GRO1
induction trend, i.e. 8- and 20-fold induction (2 hpi) and
38- and 95-fold induction (24 hpi) (microarray and Northern,
respectively).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 3.
Northern blot analysis of microarray
expression data. RNA was purified from mock- and parasite-infected
HFFs 2 hpi (right panel) and 24 hpi (left panel)
and hybridized to microarrays. The same total RNA was separated by
agarose gel electrophoresis and Northern-blotted with probes against
GRO1 (induced), DKK1 (repressed), and -actin (unmodulated).
|
|
To determine whether the change in GRO1 mRNA levels
reflects a change in the GRO1 protein produced, we used an ELISA-based assay to determine the amount of this chemokine in the medium of
uninfected versus T. gondii-infected HFF
cultures. The results indicated that 4 hpi of T. gondii
stimulated an increase in the GRO1 concentration from ~600 to ~9000
pg/ml (data not shown). These results are in good agreement with the 8- to 20-fold induction of GRO1 mRNA indicated by the microarray and
Northern blot data.
T. gondii Up-regulates the Abundance of Host Glycolytic and
Mevalonate Metabolic Transcripts--
To examine the late pattern of
gene expression in greater detail, two independent 24-h infections were
analyzed with microarrays. The data were filtered to identify genes
whose spots were of high quality and in both experiments were up- or
down-modulated at least 2-fold. Using these criteria, 567 unique genes
were identified of which 376 corresponded to previously characterized
genes with some functional information while 191 were ESTs or genes of
unknown function. Categorizing the known genes by function indicated
that numerous cellular processes are modulated during T. gondii infection. These included genes involved in carbohydrate
and lipid metabolism (13.7%); transcriptional regulation (13.2%);
protein synthesis, targeting, and degradation (12.3%); cell signaling
(11.4%); inflammation (8.2%); cell adhesion and cytoskeleton (8.2%);
nucleotide and amino acid metabolism (4.7%); cell cycle (4.1%); and
apoptosis (3%). It is important to note that this type of functional
annotation may be misleading, because some genes may be involved in
more than one process but have been arbitrarily grouped into a single class. For example, although ICAM1 is an adhesion molecule, its expression is often associated with the inflammatory response (26).
Because the list of modulated known genes and unknown ESTs is too large
to be presented in this report, the list can be downloaded from
J.C.B.'s website at Stanford University. Examination of those
down-regulated genes revealed no clear trends for any group of genes
involved in a particular function or pathway. Examination of the
up-regulated genes, however, showed some clear functional groupings and
is discussed below.
Similar to other intracellular parasites, T. gondii must
scavenge from its host nutrients such as glucose and cholesterol (27).
Interestingly, our results show that many enzymes associated with these
pathways are up-regulated during infection.
Glycolysis--
Glycolysis is a 10-step metabolic pathway that
converts glucose to 2 molar equivalents of pyruvate with a net yield of
2 molar equivalents of ATP. Genes encoding each of the host glycolytic enzymes were present on these microarrays. Of these genes,
hexokinase 2, phosphofructokinase 1, triose
phosphate isomerase 1, phosphoglycerate kinase,
phosphoglycerate mutase 1, and enolase 2 were
significantly up-regulated 2-fold (Fig.
4). However, glucose phosphate
isomerase, aldolase A, and pyruvate kinase 1 were not significantly changed. Glyceraldehyde-3-phosphate
dehydrogenase was up-regulated (3.7-fold) in one experiment, and
in the second, it was up-regulated ~1.8-fold, which is below the
minimal threshold of significance.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
Transcriptional changes of genes involved in
glycolysis and squalene biosynthesis. Shown are the -fold changes
for genes 24 hpi encoding enzymes involved in glycolysis
(left) and squalene metabolism (right). (Induced); NC (no change); PS (poor spot);
NP (not printed on the microarrays).
|
|
Depending on the aerobic status of the host, pyruvate is further
metabolized to either lactate or acetyl-CoA. Microarray data indicated
that lactate dehydrogenase-A (muscle isoform) was
up-regulated 24 hpi. Besides lactate dehydrogenase-A, two
other lactate dehydrogenase isoforms have been previously characterized
(lactate dehydrogenase-B (heart isoform) and lactate
dehydrogenase-C (sperm isoform)) (28). Of these, lactate
dehydrogenase-B was not spotted on the microarrays, and the spot
for lactate dehydrogenase-C was of insufficient intensity to
be included in our analysis, suggesting that it is not expressed in
HFFs. Acetyl-CoA, which is generated from pyruvate by the pyruvate dehydrogenase complex, can be utilized by the TCA cycle that is coupled
to oxidative phosphorylation. We found that expression of pyruvate
dehydrogenase complex genes was not significantly changed during
T. gondii infection. Moreover, pyruvate dehydrogenase kinase isoenzyme 1, which is a negative regulator of pyruvate dehydrogenase, was up-regulated ~2.5-fold.
Fructose-bisphosphatase, which catalyzes the rate-limiting
reaction in gluconeogenesis, was not significantly altered 24 hpi.
Genes encoding components of the nine TCA cycle holoenzymes, except
succinyl-CoA synthase, were spotted on the microarrays, and
none were significantly induced or repressed during infection.
Similarly, no significant changes were observed in the expression of
genes encoding enzymes involved in either amino acid catabolism, which
yield either pyruvate or acetyl-CoA, or in the pentose phosphate
pathway. Together, these data suggest that T. gondii
stimulates the specific up-regulation of transcripts involved in
anaerobic glycolysis but not oxidative phosphorylation.
Cholesterol Biosynthesis--
T. gondii cannot synthesize sterols
via the mevalonate pathway and, therefore, must obtain them from the
host cell (29). There are three mechanisms that cells employ to
replenish depleted cholesterol stores: 1) stimulation of de
novo cholesterol biosynthesis via the mevalonate pathway; 2)
enhanced LDL uptake; or 3) mobilization of intracellular cholesterol
esters. Although T. gondii appears to acquire cholesterol by
subverting the LDL trafficking pathway (29), it is not clear what
effect this has on the host. De novo cholesterol
biosynthesis is dependent on the mevalonate pathway that metabolizes
HMG-CoA to squalene. Examination of the genes on the microarrays
encoding enzymes involved in the mevalonate pathway indicated that
several were induced 24 hpi. These include the rate-limiting enzyme
HMG-CoA reductase, diphosphomevalonate decarboxylase, and farnesyl pyrophosphate synthase.
Mevalonate 5-phosphotransferase and phosphomevalonate
kinase showed no significant change while the spot for
isopentylpyrophosphate isomerase was of insufficient quality
in all replicas and thus was not included in the analysis. Moreover,
squalene epoxidase, which is the second enzyme in the
committed cholesterol biosynthetic pathway, producing 2,3-oxidosqualene, was up-regulated 5-fold following infection, suggesting that induction of mevalonate biosynthetic enzymes may be
necessary to increase levels of cellular squalene. Farnesyl pyrophosphate, the squalene precursor, is also a substrate for several
other metabolic pathways, including dolichol and terpenoid biosynthesis. Two key enzymes in dolichol metabolism,
dolichyl-phosphate N-acetylglucosamine phosphotransferase 1 and dolichyl-phosphate mannosyltransferase, which
were spotted onto the microarrays, were not significantly changed 24 hpi. Regulation of these genes may be very complex, because the
induction of mevalonate metabolic genes did not always occur at 24 hpi.
The microarray experiments were repeated six times, and the genes were
significantly induced in five of six experiments, including the two
used for this analysis. These data indicate that infection with
T. gondii stimulates up-regulation of several key genes
involved in mevalonate metabolism.
Infected Conditioned Medium Reveal a Role for Soluble Factors in
Modulating the Transcriptional Response--
One drawback of these
assays is that it is not possible to discriminate between those genes
modulated by intracellular parasites and those modulated by factors
secreted from either infected host cells or from the parasites
themselves. For example, the microarray data indicate that T. gondii-infected HFFs synthesize IL-1 . The release of these
proteins may activate neighboring cells regardless of whether they are
infected or not. Moreover, T. gondii secretes proteins from
intracellular organelles and sheds cell surface proteins that, similar
to intact parasites, bind cells and stimulate chemokine and cytokine
expression (30-34). Thus, it is necessary to determine which genes are
modulated directly by infection and which are modulated by soluble
factors derived from either the infected host or the parasite itself.
First, filtered conditioned media from mock- and
parasite-infected cells was used to discriminate between genes
regulated only in the presence of T. gondii and genes
modulated by secreted factors. Media from 24-hpi mock- and
parasite-infected HFFs were collected, filtered, and added to
uninfected HFF monolayers. RNA was harvested at 4, 14, and 24 h
from each conditioned media-treated monolayer as well as from the
24-hpi mock- and parasite-infected cells from which the conditioned
media was obtained. Each microarray was hybridized with labeled
cDNA prepared from each time point and analyzed and clustered as in
Fig. 1. Gene clustering indicated that two classes of genes were
modulated during infection: 1) those regulated by both conditioned
media and T. gondii and 2) those regulated only in the
presence of T. gondii (Fig. 5
and the dataset can be downloaded from Stanford University on the Web).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of infected HFF-conditioned media on
gene expression in uninfected HFFs. Media from 24-hpi mock- and
T. gondii-infected cultures were collected and filtered
through a 0.2-µm filter. The filtered conditioned media were added to
uninfected HFF monolayers for 4, 14, and 24 h. cDNA, prepared
from RNA harvested from the treated cultures as well as the original
mock- and T. gondii-infected cultures used to generate the
conditioned media, was hybridized to microarrays. Shown is the gene
cluster for spots of high quality representing unique genes that change
>2-fold. Five major classes of genes are seen in the gene cluster: 1)
genes up-regulated by conditioned media and infection, 2) genes
up-regulated only during infection, 3) genes modulated only by the
conditioned media, 4) genes down-regulated only during infection, and
5) genes down-regulated by infection and conditioned media.
|
|
The early response genes that remained up-regulated 24 hpi (such as
GRO1, IL-1 , IL-6, GTP
cyclohydrolase, ICAM 1, and I B alpha) were also up-regulated by conditioned media from T. gondii-infected HFFs. Besides the early response genes, other
genes up-regulated 24 hpi were also up-regulated by the conditioned
media and include IL-13 receptor alpha 2, IL-7
receptor, and BCL2/adenovirus E1B 19kDa-interacting protein 3. These data indicate that
these genes were modulated by secreted factors derived either from the
parasite or the infected host cell.
Genes modulated by infection but not by the infected conditioned media
suggested that their transcriptional regulation was a direct
consequence of intracellular infection and growth. Examination of the
mevalonate metabolic genes, which were up-regulated 24 hpi, indicated
that they were not up-regulated by the conditioned media. These include
HMG-CoA reductase, farnesyl pyrophosphate synthase, and squalene epoxidase. The spot
corresponding to the other induced mevalonate metabolic gene,
mevalonate decarboxylase, was of poor quality in the
microarrays used for these experiments and therefore, not included in
this analysis.
Of the glycolytic genes induced by T. gondii 24 hpi and
represented by spots of high quality in these experiments, triose phosphate isomerase 1, phosphoglycerate kinase 1,
phosphoglycerate mutase 1, and lactate
dehydrogenase-A were not induced by the conditioned media.
Hexokinase 2 was not spotted on these microarrays, and the
spot representing phosphofructokinase 1 was of poor quality. Because glyceraldehyde-3-phosphate dehydrogenase 2 and
enolase were induced by the conditioned media, these data
indicate that transcriptional regulation of glycolytic genes may be
complex and requires further investigation to determine whether their modulation is regulated directly by T. gondii infection or
by secreted factors.
Next, HFFs were treated with cycloheximide to prevent new protein
synthesis following infection and thus, prevent secondary effects from
the first wave of gene expression. HFFs were incubated with or without
cycloheximide (100 µg/ml) 30 min prior to infection and then mock- or
parasite-infected for 2 h in the continued presence of
cycloheximide. The toxic effect of cycloheximide to the HFFs was
minimized by determining, using 35S incorporation, that
this concentration and time was the minimal amount needed to block
>95% de novo protein synthesis (not shown). The expression
levels of the early response genes were compared by hybridizing two
different microarrays with cDNA prepared from mock- and
parasite-infected cultures grown with or without cycloheximide. The
majority (>82%) of the early response genes (whose spots were of
good quality) were induced in the presence of cycloheximide (Table
I). These included GRO1,
IL-6, IL-1 , c-REL
NF- B (p105), ICAM1, interferon
regulatory factor 1, c-Jun, LIF,
pre-B-cell colony-enhancing factor, immediate early
response 3, TNF- -induced protein, and
TNF- -induced protein 3. Thus, induction of
early response genes is largely independent on the synthesis of
host-derived factors.
View this table:
[in this window]
[in a new window]
|
Table I
Effect of cycloheximide on the early response genes
HFFs were mock-treated or cycloheximide (CHX)-treated (100 µg/ml) for
30 min prior to addition of media or parasites. Uninfected and infected
cDNA samples from either mock-treated or CHX-treated cells were
compared by microarray analysis. Early response genes denoted
"CHX-resistant" were induced in both mock-treated and CHX-treated
infected cells. Early response genes denoted "CHX-sensitive" were
induced in only the mock-treated infected cells.
|
|
Host Gene Regulation by Soluble Toxoplasma-derived
Factors--
Previously, it has been demonstrated that intact
extracellular T. gondii tachyzoites secrete factors that
stimulate expression of some immune response genes (32-34). Therefore,
we hypothesized that induction of early response genes in the
conditioned media and the cycloheximide experiments may be largely
mediated by factors secreted from the parasites. Direct host-parasite
interaction was blocked by adding parasites to the upper compartment of
a Transwell chamber in which HFFs were plated in the lower compartment. More tachyzoites (5-fold more) were added to the Transwell chamber than
normally used to infect a monolayer to allow for the dilution and
distance separating parasites from the host cells. After 4 h, RNA
was extracted from the HFFs and compared with RNA prepared from
mock-treated HFFs in which only media was added to the upper Transwell
compartment. In parallel, RNA was prepared from HFF monolayers that
were either mock- or parasite-infected for 4 h in the absence of a
Transwell chamber. The cDNAs were compared by microarray analysis,
and the data indicated that all but one of the early response genes
represented by spots of high quality, plasma membrane
Ca2+ ATPase, were similarly induced by
parasites in contact with the host cell as by parasites in the
Transwell chamber (Fig. 6). These data
indicate that exposure to secreted, soluble parasite-derived factors
can stimulate transcription of the early response genes.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 6.
T. gondii-derived soluble,
secreted factors modulate gene expression in HFFs. Serum-free DMEM
and 1 × 107 or 1 × 108 intact
parasites were added to the upper compartment of a 10-cm transwell
chamber in which HFFs were plated in the lower compartment. In
parallel, HFFs were mock- or parasite-infected in the absence of a
transwell. RNA was harvested from HFFs and cDNA hybridized to
microarrays. Shown is a gene cluster of the of the early response genes
from Fig. 2.
|
|
To exclude the possibility that a small number of host cells
contaminate the parasite preparation and that in response to the
parasite suspension these host cells are responsible for production of
the soluble factor, we performed the following experiments. First, we
incubated our purified parasites in the same medium and for the same
time as used in the transwell experiments and then removed the medium
and assayed it for the presence of GRO1. (As discussed above, GRO1 is
abundantly produced by infected cells and thus serves as an easily
assayed marker for the presence of soluble factors released by such
cells.) No GRO1 could be detected in the medium using an ELISA-based
assay that is sensitive down to 25 pg/ml (data not shown). These
results show that, to the limit of sensitivity of this assay, there are
no contaminating host cells in our purified parasite preparation. Next,
we determined how much host cell-derived factors (again monitored
through GRO1) would be needed to elicit a response. To do this, various
dilutions of conditioned media from mock- or T. gondii-infected (4 hpi) cultures were added to uninfected HFFs for
4 h. The net amount of GRO1 produced was determined by subtracting
the amount of GRO1 initially added to the cells from the amount of GRO1
produced after the 4-h incubation. The data showed that even a 1:10
dilution of T. gondii-infected conditioned media (which
contains 50 pg/ml GRO1) was not able to stimulate a substantial net
amount of GRO1 (not shown). Moreover, the amount of GRO1 produced by
the cells, to which the 1:10 and lower dilutions of T. gondii-infected conditioned media was added, was comparable to the
amount of GRO1 constitutively produced by cells to which only undiluted
mock-infected conditioned media was added. Thus, if there are host
cells contaminating the parasite suspension, they are too few to
produce the amount of host-derived material (e.g. <25 pg/ml
GRO1) to activate an autocrine response and, therefore, we conclude
that the soluble factor is parasite-derived.
 |
DISCUSSION |
Large-scale expression analysis is rapidly becoming an important
tool to study parasite-host interactions. In this study, the response
of HFFs to T. gondii was characterized and found that within
1-2 hpi infected cells rapidly respond to infection by up-regulating
the expression of numerous genes associated with the immune response.
Much of this response does not require direct contact between the
parasite and host cell, but rather, is regulated via secreted,
parasite-derived factors. In addition, two metabolic pathways were
identified that are transcriptionally up-regulated by infection.
Finally, experiments were performed to identify candidate host genes
that are modulated only in the presence of the parasite.
Although HFFs are not considered a major target for T. gondii in
vivo, they do apparently reflect many features seen in other cell
types as well as the infected animal. For example, many of the cytokine
and chemokine genes induced in HFFs are the same as those induced in
monocytes and in vivo during mouse infection (4, 7).
Chemokines function to recruit immune cells, such as macrophages,
dendritic cells, and neutrophils, to sites of infection, and their
synthesis has been proposed as an important component in cell-mediated
immunity to T. gondii (35). The cellular source of these
chemokines is unknown but has been proposed to originate from both
infected cells and other cells recruited to the site of infection
(35).
To address whether the pro-inflammatory genes induced early during
infection could be a nonspecific response of HFFs to intracellular parasitism (i.e. independent of the pathogen), we compared
the response of the same HFFs to another intracellular protozoan
parasite, Trypanosoma cruzi, using replicate microarrays and
the same data analysis methods as for the T. gondii
experiments. We found that only ~4% (23 of 614) of the genes,
modulated by T. gondii 24 hpi, were also modulated by
T. cruzi 24 hpi.2
Of these 23, only three (MCP1, pre-B-cell
colony-enhancing factor, and bradykinin receptor B2)
are up-regulated 2 hpi with T. gondii, indicating that these
genes do not represent a general HFF response to intracellular
protozoan parasites.
Although we, like others, are interested in the function of the genes
modulated during infection, microarrays also allow the identification
of candidate intracellular signaling pathways that are activated by the
parasite and lead to host gene regulation. One candidate pathway
involves the NF- B family of transcription factors, which is
important in both innate and cell-mediated immune responses to T. gondii (36). Stimulation of NF- B-dependent transcription leads to the induction of many of the early response genes that are stimulated within 2 hpi. These include the NF- B subunits REL-B, NF- B p105, as
well as I- B , GRO1, GRO2,
ICAM1, and c-myc (37, 38). Moreover,
MCP1 induction by T. gondii requires NF- B
activation (5). In vivo, protection against T. gondii infection requires NF- B activation in immune effector cells, but a role for NF- B activation in the primary infected cell
remains unclear (36, 39). The finding here that soluble T. gondii-derived factors, as well as intact parasites, induce a
similar repertoire of cytokines and chemokines in HFFs as they do in
other cell types (4, 7) suggests that the signaling pathways activated
are similar between the different cell types.
Changes in host cell metabolism as a consequence of nutrient scavenging
by intracellular parasites is difficult to study biochemically because
of the inability to effectively separate parasite-derived activities
from the host functions. Thus, the microarray data presented here
provide the first description of the response of host glycolytic and
mevalonate pathways, which were not previously suspected of being
transcriptionally regulated during T. gondii infection.
Compared with most other genes involved in carbohydrate or energy
metabolism that remained unchanged during infection, glycolytic genes
were significantly up-regulated, suggesting that intracellular T. gondii growth may induce an anaerobic environment that may result
from a general starvation or stress response. Moreover, these data may
represent a metabolic basis for the finding that bradyzoite cysts are
predominantly found in tissues (brain and muscle) that are major users
of glycolysis (40).
A second explanation for the induction of glycolytic enzymes could be
that parasites may use pyruvate or acetyl-CoA as primary carbon
sources. This possibility seems unlikely, because transcript levels of
host genes encoding enzymes involved in amino acid catabolism to
pyruvate or acetyl-CoA remained unchanged during infection. Moreover,
many of the glycolytic enzymes are abundantly expressed in T. gondii, suggesting that parasites can utilize glucose as a carbon
source (41). A third explanation is that these genes are induced
nonspecifically as an incidental by-product of a response needed for
other purposes and is discussed further below.
Up-regulation of mevalonate metabolic enzyme transcripts may be due to
the fact that T. gondii appears to scavenge cholesterol by
subverting LDL trafficking. Thus, the infected cell may sense loss of
LDL cellular pools and respond by up-regulating expression of these
enzymes. Interestingly, Coppens et al. (29) did not observe
any increase in bulk HMG-CoA reductase enzymatic activity in Chinese
hamster ovary cells infected with a rapidly growing, highly virulent
type I T. gondii strain (RH). The reason for this discrepancy is unclear and may indicate a difference in the flux rate
of HMG-CoA through the pathway between uninfected and infected HFFs. In
addition, these data may reflect differences between different cell
types (HFFs versus Chinese hamster ovary cells) and/or
parasite strains (RH versus PDS) used in the two studies.
Host genes modulated during infection represent three functionally
distinct classes: 1) genes required for host defense, 2) genes required
for parasite growth, and 3) genes incidentally regulated as a
consequence of modulating the first two classes. How the genes
identified by microarray analysis in this study fit into these three
groups and what parasite factors are involved cannot be deduced from
the work presented here. However, such assignments will be possible by
combining microarrays with biochemical and cell biological analysis of
mutant host cells and parasite strains.
 |
ACKNOWLEDGEMENTS |
We thank Drs. Barbara Burleigh, Karen
Guilliman, Ed Mocarski, Silvia Vaena, and Tina Wasson-Blader for
critical reading of the manuscript and members of the Boothroyd
laboratory for helpful discussion. Also, we thank Dr. Jason Lih,
Jeannette Lam, and Kimberly Chong for microarray preparation and
Dr. Gavin Sherlock and the Stanford Microarray Data base for
bioinformatic support and guidance.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by National Institutes of Health Grant 1F32AI10478-01.
§
Current address: Mycometrix, 213 E. Grand Ave., South San
Francisco, CA 94080.
¶
Supported by National Institutes of Health Grants AI21423 and
AI45057. To whom correspondence should be addressed: Dept. of Microbiology and Immunology, Stanford University, 299 Campus Dr., Stanford, CA 94305-5124. Tel.: 650-723-7984; Fax: 650-723-6853; E-mail:
john.boothroyd@Stanford.edu.
Published, JBC Papers in Press, April 9, 2001, DOI 10.1074/jbc.M100951200
2
S. Vaena, I. J. Blader, J. C. Boothroyd, and B. Burleigh, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
IFN- , interferon
;
HFFs, human foreskin fibroblasts;
hpi, hours post-infection;
TCA, tricarboxylic acid;
DMEM, Dulbecco's modified Eagle's medium;
ELISA, enzyme-linked immunosorbent assay;
IL-1, interleukin-1;
TNF- , tumor
necrosis factor ;
EST, expressed sequence tag;
LDL, low density
lipoprotein;
HMG-CoA, 3-hydroxy-3-methylglutaryl-Coenzyme
A.
 |
REFERENCES |
| 1.
|
Luft, B. J.,
and Remington, J. S.
(1992)
Clin. Infect. Dis.
15,
211-222
|
| 2.
|
Sinai, A. P.,
Webster, P.,
and Joiner, K. A.
(1997)
J. Cell Sci.
110,
2117-2128
|
| 3.
|
Schwartzman, J. D.,
and Pfefferkorn, E. R.
(1982)
Exp. Parasitol.
53,
77-86
|
| 4.
|
Li, Z. Y.,
Manthey, C. L.,
Perera, P. Y.,
Sher, A.,
and Vogel, S. N.
(1994)
Infect. Immun.
62,
3434-3440
|
| 5.
|
Brenier-Pinchart, M. P.,
Pelloux, H.,
Simon, J.,
Ricard, J.,
Bosson, J. L.,
and Ambroise-Thomas, P.
(2000)
Mol. Cell Biochem.
209,
79-87
|
| 6.
|
Yap, G. S.,
and Sher, A.
(1999)
Immunobiology
201,
240-247
|
| 7.
|
Denney, C. F.,
Eckmann, L.,
and Reed, S. L.
(1999)
Infect. Immun.
67,
1547-1552
|
| 8.
|
Alexander, J.,
Scharton-Kersten, T. M.,
Yap, G.,
Roberts, C. W.,
Liew, F. Y.,
and Sher, A.
(1997)
Philos. Trans. R. Soc. Lond. B Biol. Sci.
352,
1355-1359
|
| 9.
|
Yap, G.,
Pesin, M.,
and Sher, A.
(2000)
J. Immunol.
165,
628-631
|
| 10.
|
Aliberti, J.,
Sousa, C. R. E.,
Schito, M.,
Hieny, S.,
Wells, T.,
Huffnagel, G. B.,
and Sher, A.
(2000)
Nat. Immunol.
1,
83-87
|
| 11.
|
Manger, I. D.,
and Relman, D. A.
(2000)
Curr. Opin. Immunol.
12,
215-218
|
| 12.
|
Eisen, M. B.,
and Brown, P. O.
(1999)
Methods Enzymol.
303,
179-205
|
| 13.
|
Zhu, H.,
Cong, J. P.,
Mamtora, G.,
Gingeras, T.,
and Shenk, T.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14470-14475
|
| 14.
|
Rosenberger, C. M.,
Scott, M. G.,
Gold, M. R.,
Hancock, R. E.,
and Finlay, B. B.
(2000)
J. Immunol.
164,
5894-5904
|
| 15.
|
Cohen, P.,
Bouaboula, M.,
Bellis, M.,
Baron, V.,
Jbilo, O.,
Poinot-Chazel, C.,
Galiegue, S.,
Hadibi, E. H.,
and Casellas, P.
(2000)
J. Biol. Chem.
275,
11181-11190
|
| 16.
|
Taylor, L. A.,
Carthy, C. M.,
Yang, D.,
Saad, K.,
Wong, D.,
Schreiner, G.,
Stanton, L. W.,
and McManus, B. M.
(2000)
Circ. Res.
87,
328-334
|
| 17.
|
Ichikawa, J. K.,
Norris, A.,
Bangera, M. G.,
Geiss, G. K.,
van't Wout, A. B.,
Bumgarner, R. E.,
and Lory, S.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
9659-9664
|
| 18.
|
Geiss, G. K.,
Bumgarner, R. E.,
An, M. C.,
Agy, M. B.,
van't Wout, A. B.,
Hammersmark, E.,
Carter, V. S.,
Upchurch, D.,
Mullins, J. I.,
and Katze, M. G.
(2000)
Virology
266,
8-16
|
| 19.
|
Boothroyd, J. C.,
Black, M.,
Bonnefoy, S.,
Hehl, A.,
Knoll, L. J.,
Manger, I. D.,
Ortega-Barria, E.,
and Tomavo, S.
(1997)
Philos. Trans. R. Soc. Lond-Biol. Sci.
352,
1347-1354
|
| 20.
|
Alizadeh, A. A.,
Eisen, M. B.,
Davis, R. E.,
Ma, C.,
Lossos, I. S.,
Rosenwald, A.,
Boldrick, J. C.,
Sabet, H.,
Tran, T., Yu, X.,
Powell, J. I.,
Yang, L.,
Marti, G. E.,
Moore, T.,
Hudson, J., Jr.,
Lu, L.,
Lewis, D. B.,
Tibshirani, R.,
Sherlock, G.,
Chan, W. C.,
Greiner, T. C.,
Weisenburger, D. D.,
Armitage, J. O.,
Warnke, R.,
Staudt, L. M.,
et al..
(2000)
Nature
403,
503-511
|
| 21.
|
Eisen, M. B.,
Spellman, P. T.,
Brown, P. O.,
and Botstein, D.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14863-14868
|
| 22.
|
Iyer, V. R.,
Eisen, M. B.,
Ross, D. T.,
Schuler, G.,
Moore, T.,
Lee, J. C. f.,
Trent, J. M.,
Staudt, L. M.,
Hudson, J.,
Boguske, M. S.,
Lashkari, D.,
Shalon, D.,
Botstein, D.,
and Brown, P. O.
(1999)
Science
283,
83-87
|
| 23.
|
Spellman, P. T.,
Sherlock, G.,
Zhang, M. Q.,
Iyer, V. R.,
Anders, K.,
Eisen, M. B.,
Brown, P. O.,
Botstein, D.,
and Futcher, D.
(1998)
Mol. Biol. Cell
9,
3273-3297
|
| 24.
|
Schmitz, J. L.,
Carlin, J. M.,
Borden, E. C.,
and Byrne, G. I.
(1989)
Infect. Immun.
57,
3254-3256
|
| 25.
|
Hunter, C. A.,
Subauste, C. S.,
Van Cleave, V. H.,
and Remington, J. S.
(1994)
Infect. Immun.
62,
2818-2824
|
| 26.
|
van de Stolpe, A.,
and van der Saag, P. T.
(1996)
J. Mol. Med.
74,
13-33
|
| 27.
|
Sinai, A. P.,
and Joiner, K. A.
(1997)
Annu. Rev. Microbiol.
51,
415-462
|
| 28.
|
Ansari, A. A.,
Baig, M. A.,
and Malling, H. V.
(1981)
Biochem. Biophys. Res. Commun.
102,
93-99
|
| 29.
|
Coppens, I.,
Sinai, A. P.,
and Joiner, K. A.
(2000)
J. Cell Biol.
149,
167-180
|
| 30.
|
Carruthers, V. B.,
and Sibley, L. D.
(1999)
Mol. Microbiol.
31,
421-428
|
| 31.
|
Darcy, F.,
Deslee, D.,
Santoro, F.,
Charif, H.,
Auriault, C.,
Decoster, A.,
Duquesne, V.,
and Capron, A.
(1988)
Parasite Immunol.
10,
553-567
|
| 32.
|
Channon, J. Y.,
Suh, E. I.,
Seguin, R. M.,
and Kasper, L. H.
(1999)
Infect. Immun.
67,
2547-2551
|
| 33.
|
Denkers, E. Y.,
Caspar, P.,
and Sher, A.
(1994)
J. Exp. Med.
180,
985-994
|
| 34.
|
Khan, I. A.,
Ely, K. H.,
and Kasper, L. H.
(1991)
J. Immunol.
147,
3501-3506
|
| 35.
|
Sher, A.,
Denkers, E. Y.,
and Gazzinelli, R. T.
(1995)
CIBA Found. Symp.
195,
95-104
|
| 36.
|
Caamano, J.,
Alexander, J.,
Craig, L.,
Bravo, R.,
and Hunter, C. A.
(1999)
J. Immunol.
163,
4453-4461
|
| 37.
|
May, M. J.,
and Ghosh, S.
(1997)
Semin. Cancer Biol.
8,
63-73
|
| 38.
|
May, M. J.,
and Ghosh, S.
(1998)
Immunol. Today
19,
80-88
|
| 39.
|
Caamano, J.,
Tato, C.,
Cai, G.,
Villegas, E. N.,
Speirs, K.,
Craig, L.,
Alexander, J.,
and Hunter, C. A.
(2000)
J. Immunol.
165,
5720-5728
|
| 40.
|
Luft, B. J.,
and Castro, K. G.
(1991)
Eur. J. Clin. Microbiol. Infect. Dis.
10,
178-181
|
| 41.
|
Denton, H.,
Roberts, C. W.,
Alexander, J.,
Thong, K. W.,
and Coombs, G. H.
(1996)
FEMS Microbiol. Lett.
137,
103-108
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. D. Phelps, K. R. Sweeney, and I. J. Blader
Toxoplasma gondii Rhoptry Discharge Correlates with Activation of the Early Growth Response 2 Host Cell Transcription Factor
Infect. Immun.,
October 1, 2008;
76(10):
4703 - 4712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Nelson, A. R. Jones, J. C. Carmen, A. P. Sinai, R. Burchmore, and J. M. Wastling
Modulation of the Host Cell Proteome by the Intracellular Apicomplexan Parasite Toxoplasma gondii
Infect. Immun.,
February 1, 2008;
76(2):
828 - 844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. B. Carruthers and Y. Suzuki
Effects of Toxoplasma gondii Infection on the Brain
Schizophr Bull,
May 1, 2007;
33(3):
745 - 751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Fouts and J. C. Boothroyd
Infection with Toxoplasma gondii Bradyzoites Has a Diminished Impact on Host Transcript Levels Relative to Tachyzoite Infection
Infect. Immun.,
February 1, 2007;
75(2):
634 - 642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Taylor, A. Barragan, C. Su, B. Fux, S. J. Fentress, K. Tang, W. L. Beatty, H. E. Hajj, M. Jerome, M. S. Behnke, et al.
A Secreted Serine-Threonine Kinase Determines Virulence in the Eukaryotic Pathogen Toxoplasma gondii
Science,
December 15, 2006;
314(5806):
1776 - 1780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Andersson, B. Hartmanova, P. Ryden, L. Noppa, L. Naslund, and A. Sjostedt
A microarray analysis of the murine macrophage response to infection with Francisella tularensis LVS.
J. Med. Microbiol.,
August 1, 2006;
55(Pt 8):
1023 - 1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Okomo-Adhiambo, C. Beattie, and A. Rink
cDNA Microarray Analysis of Host-Pathogen Interactions in a Porcine In Vitro Model for Toxoplasma gondii Infection
Infect. Immun.,
July 1, 2006;
74(7):
4254 - 4265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fahling, R. Mrowka, A. Steege, P. Martinka, P. B. Persson, and B. J. Thiele
Heterogeneous Nuclear Ribonucleoprotein-A2/B1 Modulate Collagen Prolyl 4-Hydroxylase, {alpha} (I) mRNA Stability
J. Biol. Chem.,
April 7, 2006;
281(14):
9279 - 9286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Molestina and A. P. Sinai
Host and parasite-derived IKK activities direct distinct temporal phases of NF-{kappa}B activation and target gene expression following Toxoplasma gondii infection
J. Cell Sci.,
December 15, 2005;
118(24):
5785 - 5796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. W. Zhou, B. F. C. Kafsack, R. N. Cole, P. Beckett, R. F. Shen, and V. B. Carruthers
The Opportunistic Pathogen Toxoplasma gondii Deploys a Diverse Legion of Invasion and Survival Proteins
J. Biol. Chem.,
October 7, 2005;
280(40):
34233 - 34244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. UNNIKRISHNAN and B. A. BURLEIGH
Inhibition of host connective tissue growth factor expression: a novel Trypanosoma cruzi-mediated response
FASEB J,
November 1, 2004;
18(14):
1625 - 1635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. N. Ledger, P. Pinton, D. Bourges, P. Roumi, H. Salmon, and I. P. Oswald
Development of a Macroarray To Specifically Analyze Immunological Gene Expression in Swine
Clin. Vaccine Immunol.,
July 1, 2004;
11(4):
691 - 698.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. R. Portugal, L. R. Fernandes, G. C. Cesar, H. C. Santiago, D. R. Oliveira, N. M. Silva, A. A. Silva, J. Lannes-Vieira, R. M. E. Arantes, R. T. Gazzinelli, et al.
Infection with Toxoplasma gondii Increases Atherosclerotic Lesion in ApoE-Deficient Mice
Infect. Immun.,
June 1, 2004;
72(6):
3571 - 3576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhao, M. L. Whitfield, T. Xu, D. Botstein, and J. D. Brooks
Diverse Effects of Methylseleninic Acid on the Transcriptional Program of Human Prostate Cancer Cells
Mol. Biol. Cell,
February 1, 2004;
15(2):
506 - 519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Molestina, T. M. Payne, I. Coppens, and A. P. Sinai
Activation of NF-{kappa}B by Toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated I{kappa}B to the parasitophorous vacuole membrane
J. Cell Sci.,
November 1, 2003;
116(21):
4359 - 4371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Payne, R. E. Molestina, and A. P. Sinai
Inhibition of caspase activation and a requirement for NF-{kappa}B function in the Toxoplasma gondii-mediated blockade of host apoptosis
J. Cell Sci.,
November 1, 2003;
116(21):
4345 - 4358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lin, M. T. Vahey, D. Thach, D. A. Stenger, and J. J. Pancrazio
Biological Threat Detection via Host Gene Expression Profiling
Clin. Chem.,
July 1, 2003;
49(7):
1045 - 1049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Natarajan, M. S. Rajala, and J. Chodosh
Corneal IL-8 Expression Following Adenovirus Infection Is Mediated by c-Src Activation in Human Corneal Fibroblasts
J. Immunol.,
June 15, 2003;
170(12):
6234 - 6243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. van 't Wout, G. K. Lehrman, S. A. Mikheeva, G. C. O'Keeffe, M. G. Katze, R. E. Bumgarner, G. K. Geiss, and J. I. Mullins
Cellular Gene Expression upon Human Immunodeficiency Virus Type 1 Infection of CD4+-T-Cell Lines
J. Virol.,
December 20, 2002;
77(2):
1392 - 1402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Mocarski Jr.
Virus self-improvement through inflammation: No pain, no gain
PNAS,
March 19, 2002;
99(6):
3362 - 3364.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. de Avalos, I. J. Blader, M. Fisher, J. C. Boothroyd, and B. A. Burleigh
Immediate/Early Response to Trypanosoma cruzi Infection Involves Minimal Modulation of Host Cell Transcription
J. Biol. Chem.,
January 4, 2002;
277(1):
639 - 644.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|